Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Ireland's COVID-19 vaccination programme is based on the principles of safety, effectiveness and fairness, with the objective of reducing severe illness, hospitalisations and deaths from COVID-19 infection.

The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). The NIAC makes recommendations on vaccination policy to the Department of Health based on the prevalence of the relevant disease in Ireland and international best practices in relation to immunisation.

Following the recommendation for use of vaccines against COVID-19 by the European Medicines Agency (EMA) and authorisation for use by the European Commission, the NIAC develops guidance for their use in Ireland which is contained in the Immunisation Guidelines for Ireland. These guidelines are continuously updated and include guidance on all new vaccines as they are approved for use in Ireland.

You can view the guidelines here: www.hse.ie/eng/health/immunisation/hcpinfo/guidelines/covid19.pdf.

The NIAC has recently advised a second booster dose for people over 65 and people with a weak immune system aged 12 and over. The Committee will continue to examine emerging evidence regarding booster vaccines for others in the population where there is evidence of waning immunity and reduced effectiveness and will make further recommendations if required.

The NIAC advised in April that they consider it likely that a third booster dose will be required for older persons and the immunocompromised in Autumn/Winter 2022. It continues to actively examine the evidence regarding the likely benefit of a second booster to other groups, vaccine choice and interval considering the likely predominant variant in order to make further recommendations in this regard.

The HSE has developed a revised operating model to underpin the continuation of the COVID-19 vaccination programme in Autumn/Winter 2022.